TrendsInterleukin 18: a pleiotropic participant in chronic inflammation
Section snippets
Biology of IL-18
Pro-IL-18 expression is widespread, and has been detected in many cell types including monocytes/macrophages, dendritic cells (DCs), Kupffer cells, keratinocytes, articular chondrocytes, synovial fibroblasts and osteoblasts, as well as within the adrenal cortex and pituitary gland2. Pro-IL-18 is cleaved by IL-1β-converting enzyme (ICE; caspase 1) to yield an active 18 kDa glycoprotein3. Alternate processing by caspase 3 or 4, or proteinase 3, is also postulated4. IL-18 recognizes a
IL-18 expression and function in inflammatory disease
The biological profile described above renders IL-18 a candidate pro-inflammatory cytokine in several autoimmune diseases. Indeed, IL-18 has recently been detected in the synovial compartment of patients with rheumatoid arthritis (RA)13. Whereas IL-18 mRNA was found in both RA and osteoarthritis (OA) synovial membranes (SMs), IL-18 protein was reproducibly detected by histology and ELISA only in RA-derived tissues. IL-18 expression was localized in RA SMs in cells of dendritic morphology within
Significance of IL-18 expression?
Although generally of a pro-inflammatory nature, not all activities thus far ascribed to IL-18 may be detrimental (Box 1). IL-18 directly suppresses angiogenesis, a process of demonstrable importance in inflammatory synovitis18. Moreover, IL-18 may inhibit osteoclast maturation through GM-CSF production, thereby retarding bone erosion. Suppression of COX expression may also be mediated through IFN-γ production.
We have therefore investigated the relative importance of IL-18 in articular
Concluding remarks
Data generated thus far indicate that IL-18 synergistically contributes both to host defence and to inflammation in a cascade of cytokines associated with innate responses, including IL-12 and IL-15 (Fig. 1). In this respect, IL-18 could modulate inflammation at multiple check points, acting not only on initiation and expansion of putative autoreactive Th/c1 responses, but also during perpetuation of synovial inflammation, independent of IFN-γ production, with direct effects on multiple
Acknowledgements
We thank the Arthritis Research Campaign (UK), The Wellcome Trust, The Scottish Chief Scientist Office and the Medical Research Council (UK) for their invaluable support.
References (22)
Interleukin-18
Methods
(1999)The role of IL-18 in innate immunity
Curr. Opin. Immunol.
(2000)Defective NK cell activity and Th1 response in IL-18-deficient mice
Immunity
(1998)Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein
J. Immunol.
(1996)Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme
Science
(1997)- et al.
Interleukin-18 and interleukin-1β: two cytokine substrates for ICE (caspase-1).
J. Clin. Immunol.
(1999) Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
Proc. Natl. Acad. Sci. U. S. A.
(2000)Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice
J. Immunol.
(1999)IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production
J. Immunol.
(1997)IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice
J. Immunol.
(1998)
IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
J. Immunol.
Cited by (189)
Role of adipokines in the pathophysiology of coronary artery disease
2023, Transcription and Translation in Health and DiseaseThe role of Interleukin-18 in recurrent early pregnancy loss
2021, Journal of Reproductive ImmunologyCitation Excerpt :Most importantly, we observed a significant upregulation of IL-18 protein expression in decidual stroma cells only in patients suffering from recurrent miscarriage compared to healthy controls. IL-18 is expressed as a precursor protein (pro-IL18) by various types of immune cells, the placenta and other tissues (McInnes et al., 2000; Tokmadzic et al., 2002; Ghayur et al., 1997). The activated inflammasome NLRP3 (NOD-, LRR- and pyrin domain containing 3) results in stimulation of caspase-1 (Mangan et al., 2018).
Double-edged sword of inflammasome genetics in colorectal cancer prognosis
2020, Clinical ImmunologyA Synthetic Human Antibody Antagonizes IL-18Rβ Signaling Through an Allosteric Mechanism
2020, Journal of Molecular Biology